Thyregod, Hans Gustav2; Søndergaard, Lars2; Ihlemann, Nikolaj3; Franzen, Olaf2; Andersen, Lars Willy2; Hansen, Peter Bo2; Olsen, Peter Skov2; Nissen, Henrik Hoffmann4; Winkel, Per2; Gluud, Christian2; Steinbrüchel, Daniel Andreas5
1 Section of Surgery and Internal Medicine, Department of Clinical Medicine, Faculty of Health and Medical Sciences, Københavns Universitet2 unknown3 LUKKET: Klinikudvalget Rigshospitalet4 Institut for Byggeri og Anlæg5 Section of Surgery and Internal Medicine, Department of Clinical Medicine, Faculty of Health and Medical Sciences, Københavns Universitet
study protocol for a randomised controlled trial
Degenerative aortic valve (AV) stenosis is the most prevalent heart valve disease in the western world. Surgical aortic valve replacement (SAVR) has until recently been the standard of treatment for patients with severe AV stenosis. Whether transcatheter aortic valve implantation (TAVI) can be offered with improved safety and similar effectiveness in a population including low-risk patients has yet to be examined in a randomised setting.